RxDoctor Payments Data

Robert Burnett, MD

Adult Reconstructive Orthopaedic Surgery · Naperville, ILNPI 1164914198

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (40.6%), education and grants — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Smith+Nephew at 28.4% of the total. Reporting peaked in 2023 at $6,949 and has fallen 56.3% since, to $3,038 in 2025.

$25,287in general payments, 2019–2025

Across 169 payments — averaging $149.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$7K
  • Medwest Associates$5K
  • Stryker$5K
  • Medacta USA, Inc.$2K
  • Zimmer Biomet$1K
  • Omnilife Science, Inc$1K
  • plus $4K from 12 others

What the payments were for

  • Grants$3,33313%
  • Travel & lodging$2,81411%
  • Food & beverage$10,27241%
  • Education$8,86835%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,287 in reported general payments places this provider in the 65th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.

See all adult reconstructive orthopaedic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$125,500
Medicare patients
254
Services billed
1,935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam109$433
Ondansetron Hcl62$287
Oxycodone Hcl69$279
Pantoprazole Sodium30$250
Tramadol Hcl69$239
Mupirocin29$202
Omeprazole31$104

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Naperville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →